I
I4P
vs
CYTH
CYTH
Over the past 12 months, I4P has underperformed CYTH, delivering a return of 0% compared to the CYTH's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
CYTH
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc
F:I4P
|
17.52
EUR
|
|||||
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
99
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
I4P, CYTH
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
I
|
Intercept Pharmaceuticals Inc
Revenue
|
|||||||||||
|
Cyclo Therapeutics Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
I4P, CYTH
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
I
|
Intercept Pharmaceuticals Inc
F:I4P
|
|||||||||
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
I
|
Intercept Pharmaceuticals Inc | ||||
|
Cyclo Therapeutics Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
I4P, CYTH
Performance By Year
I4P, CYTH
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.